Last updated on January 2010

Myelodysplastic Syndrome (MDS)


Brief description of study

Myelodysplastic Syndrome (MDS)

Detailed Study Description

To evaluate the efficacy of romiplostim for the treatment of thrombocytopenia in subjects with MDS

Patient Inclusion Criteria:

  • Diagnosis of MDS, 18+ years of age, adequate liver function, written informed consent

Patient Exclusion Criteria:

  • Have ever received any disease-modifying treatment MDS, Previously diagnosed with intermediate-2 or high risk MDS using the IPSS, prior history of leukemia, aplastic anemia, prior history of hematopoietic stem cell transplantation, active or uncontrolled infections, unstable angina, pregnant or breast feeding

Clinical Study Identifier: TX134744

Contact Investigators or Research Sites near you

Start Over

Dr. Tom Davis

Legacy Pharma Research
Bismarck, ND USA
  Connect »